Assessing FLAURA2's Influence: How Has It Shaped Your First-Line Treatment Strategy?

Opinion
Video

Following the 2024 ASCO Annual Meeting, medical oncologists share insights on how the availability of the FLAURA2 treatment regimen has impacted the treatment of patients with advanced EGFR-mutant non–small cell lung cancer (NSCLC).

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
2 experts in this video
2 experts in this video
1 expert in this video
1 expert in this video
1 expert in this video
2 experts in this video
2 experts in this video
Future work may focus on determining strategies for protecting the health of patients who undergo surgery during climate disasters.
Related Content